Characterization of the Interruptions of the GAA Expansion and Study of Their Influence on the Severity of Friedreich's Ataxia

NCT ID: NCT04346238

Last Updated: 2020-04-16

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 120 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2020-03-01
• Study Completion Date: 2021-09-30

Brief Summary

Friedreich's ataxia (FA) is the most frequent recessive genetic ataxia with an estimated prevalence of 1/50 000. The first symptoms appear around the age of 10 years with a progressive course and the need for an armchair 10- 15 years after the first symptoms. More rarely the disease can present with a late onset (after the age of 25) with a picture characterized by spastic paraparesis and slower progression ("LOFA" for "Late Onset Friedreich Ataxia" or VLOFA for "Very Late Appearance of Friedreich's ataxia ").

AF is caused in 96% of cases by an expansion of GAAN triplets (N> 100 repeats) located in intron 1 of the FXN gene, present on the two alleles, and, in the rest of the cases, by an associated expansion a point mutation or a deletion in trans. During molecular diagnostics, it is not uncommon to find the presence of interruptions within the GAA expansion. This results in the absence and / or the shift of peak (s) within the chromatogram.

To date, only the partial correlation between the size of the expansion and the age of onset of Friedreich's ataxia has been established. In particular, very atypical forms of AF with a late onset (after the age of 25) are in particular explained by the low number of repetitions in the expansion, typically between 100 and 500 repetitions. However, the presence of an interruption could stabilize the size of the expansion and, therefore, be mainly associated with expansions of small sizes and therefore with a late onset of the disease.

The objective of this study is therefore to analyse and caracterize the presence and the type of interruptions of the GAA expansions in a group of patients with FA ; this data will be correlated with the age at onset of FA.

Conditions

Friedreich Ataxia

Study Design

• Observational Model Type: CASE_ONLY
• Study Time Perspective: RETROSPECTIVE

Study Groups

Patients with Friedriech Ataxia genetically confirmed

Patients with Friedriech Ataxia genetically confirmed

Reuse of existing data from patients' medical records

Intervention Type: OTHER

Reuse of existing data from patients' medical records

Interventions

Reuse of existing data from patients' medical records

Reuse of existing data from patients' medical records

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Subjects with diagnosis of genetically confirmed Friedreich's Ataxia (AF) and :
• two expansions of GAAN triplets (> 100 repetitions or "premutation", corresponding to> 32 but <100 repetitions) located in intron 1 of the FXN gene present on the two alleles;
• symptomatic (SARA scale> 4);
• having signed a consent for the performance of genetic analyzes which also includes the authorization for the conduct of further studies for research purposes and the authorization for the collection, entry and computer processing of medical data, in all confidentiality. A newsletter on the principle of non-opposition will be sent.

Exclusion Criteria

• Patients with Friedreich's ataxia due to an expansion associated with a point mutation or a deletion in trans;
• Patients who, at the time of signing the genetic consent, objected to the use of their data for research purposes.

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Neurogenetic department, CHU Bordeaux

UNKNOWN

Sponsor Role: collaborator

Genetic Department , CHU Montpellier-France

UNKNOWN

Sponsor Role: collaborator

Neurology department, CHU La réunion

UNKNOWN

Sponsor Role: collaborator

University Hospital, Montpellier

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Cecilia Marelli, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospitals of Montpellier

Locations

Uh Montpellier

Montpellier, , France

Countries

France

Other Identifiers

RECHMPL20_0029

Identifier Type: -

Identifier Source: org_study_id